FOLD earnings call for the period ending June 30, 2020.
News & Analysis: Amicus Therapeutics
FOLD earnings call for the period ending March 31, 2020.
These five biotech stocks could post life-changing gains for early-bird investors.
Amicus Therapeutics, Amarin, and CRISPR Therapeutics are all way oversold.
FOLD earnings call for the period ending December 31, 2019.
These companies could crush the broader markets this year.
An analyst upgrade is driving Amicus' stock higher today.
FOLD earnings call for the period ending September 30, 2019.
The gene therapy stock is trading at its lowest level in over two years. It recently announced preliminary third-quarter 2019 operating results.
The competitive outlook for a key therapy is worrying investors.